Treatment of subclinical injuries detected by protocol biopsy improves the long-term kidney allograft function: A single center prospective randomized clinical trial

Transplantation Proceedings

Volumn 43, Issue 4, 2011, Pages 1239-1243

  Szederkenyi E ^a   Ivanyi B ^a   Morvay, Z ^a   Szenohradszki, P ^a   Borda, B ^a   Marofka, F ^a   Kemeny E ^a   Lazar G ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCINEURIN INHIBITOR; RAPAMYCIN;

ACUTE GRAFT REJECTION; ACUTE PYELONEPHRITIS; ADULT; CHRONIC GRAFT REJECTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; POLYOMA VIRUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ASYMPTOMATIC DISEASES; BIOPSY; CHI-SQUARE DISTRIBUTION; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HUNGARY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79957588550     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.03.078     Document Type: Conference Paper

References (27)

1. Shimizu T, Tanabe K, Ishida H, et al: Detection of subclinical humoral and/or vascular rejection by protocol biopsies in highly sensitized renal transplant recipients. Am J Transplant 4(Suppl 8):206, 2004
2. Lipman ML, Lavery P, Shi Y, et al: Incidence of subclinical rejection in protocol biopsies procured from renal transplant recipients on tacrolimus-based immunosuppressive regimen. Am J Transplant 4(Suppl 8):551, 2004
3. Seron D, Moreso F, Fulladosa X, et al: Reliability of chronic allograft nephropathy diagnosis in sequential protocol biopsies. Kidney Int 61:727, 2002
4. Rush DN, Karpinski ME, Nickerson P, et al: Does subclinical rejection contribute to chronic rejection in renal transplant patients? Clin Transplant 13:441, 1999
5. Kumar MSA, Heifets M, Fyfe B, et al: A prospective randomized study to compare the efficacy and safety of sirolimus (SIR) and mycophenolate mofetil (MMF) monitored by protocol biopsies in tacrolimus (TAC) based steroid free immunosuppression. Am J Transplant 4(Suppl 8):216, 2004
6. Eikmans M, Roos MC, Baelde HJ, et al: Transforming growth factor-beta in follow-up kidney protocol biopsies from a randomized trial comparing cyclosporine-based and tacrolimus-based immunosuppressive regimens. Am J Transplant 4(Suppl 8):224, 2004
7. Furness PN, Philpott CM, Chorbadjian MT, et al: Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 76:969, 2003
8. Schwarz A, Gwinner W, Hiss M, et al: Safety and adequacy of renal transplant biopsy protocols. Am J Transplant 5:1992, 2005
9. Wilkinson A: Protocol transplant biopsies: are they really needed? Clin J Am Soc Nephrol 1:130, 2006
10. Racusen LC, Colvin RB, Solez K, et al: Antibody-mediated rejection criteria-an addition to the Banff '97 classification of renal allograft rejection. Am J Transplant 3:1, 2003
11. Levey AS, Greene T, Kusek JW, Beck GJ: A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11:155A, 2000
12. Poggio ED, Wang X, Weinstein D.M, et al: Assessing glomerular filtration rate by estimation equation in kidney transplant recipients. Am J Transplant 6:100, 2006
13. Nickerson P, Jeffery J, Gough J, et al: Identification of clinical and histopathologic risk factors for diminished renal function 2 years posttransplant. J Am Soc Nephrol 9:482, 1998
14. Rush D, Nickerson P, Gough J, et al: Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 9:2129, 1998
15. Kee TY, Chapman JR, O'Connell PJ, et al: Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 82:36, 2006
16. Nankivell BJ, Chapman JR: The significance of subclinical rejection and the value of protocol biopsies. Am J Transplant 6:2006, 2006
17. Mao Y, Chen J, Shou Z, Wu J, et al: Clinical significance of protocol biopsy at one month posttransplantation in deceased-donor renal transplantation. Transpl Immunol 17:211, 2007
18. Masin-Spasovska J, Spasovski G, Dzikova S, et al: Do we have to treat subclinical rejections in early protocol renal allograft biopsies?. Transplant Proc 39:2550, 2007
19. Scholten EM, Rowshani AT, Cremers S, et al: Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol 17:2622, 2006
20. Rush D, Arlen D, Boucher A, et al: Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant 7:2538, 2007
21. Rush D: Protocol transplant biopsies: an underutilized tool in kidney transplantation. Clin J Am Soc Nephrol 1:138, 2006
22. Thaunat O, Legendre C, Morelon E, et al: To biopsy or not to biopsy? Should we screen the histology of stable renal grafts? Transplantation 84:671, 2007
23. Bohmig GA, Regele H, Hort WH: Protocol biopsies after kidney transplantation. Transpl Int 18:131, 2005
24. Racusen LC: Protocol transplant biopsies in kidney allografts: why and when are they indicated? Clin J Am Soc Nephrol 1:144, 2006
25. Helanterä I, Ortiz F, Helin H, et al: Timing and value of protocol biopsies in well-matched kidney transplant recipients-a clinical and histopathologic analysis. Transpl Int 20:982, 2007
26. Qureshi F, Rabb H, Kasiske BL: Silent acute rejection during prolonged delayed graft function reduces allograft survival. Transplantation 74:1400, 2002
27. Morath C, Ritz E, Zeier M. Protocol biopsy: what is the rationale and what is the evidence? Nephrol Dial Transplant 18:644, 2003